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Abstrak
Latar Belakang: Sistem surveilans nasional untuk infeksi saluran pernafasan akut berat (SARI) dapat 
memberikan informasi penting tentang sirkulasi virus influenza, menyediakan sistem untuk mengenda-
likan kejadian luar biasa yang mengancam keamanan dan keselamatan masyarakat serta menyediakan 
data untuk sistem surveilans influenza global (GISRS). Kemampuan Indonesia untuk mendeteksi dan men-
gendalikan penyakit menular penting untuk keamanan kesehatan dunia. Penelitian ini bertujuan untuk 
menilai sistem surveilans ISPA berat Indonesia (SIBI) dan pemanfaatan untuk  memantau patogen priori-
tas lainnya sebagai upaya meningkatkan keamanan kesehatan global.
Metode: penilaian atribut surveilans melalui review laporan, analisis data dan interview staff yang terlibat 
dalam sistem surveilans. Semua kasus yang memenuhi kriteria SARI pada bulan Mei 2013 – April 2015 ikut 
serta dalam penelitian. Data epidemiologi dan virologi dianalisis. Kelengkapan dan kemudahan  sistem un-
tuk mencapai tujuan surveilans influenza dan mendukung surveilans penyakit infeksi baru (emerging) dikaji.
Hasil: Sebanyak 1,806 kasus SARI dan 1,697 (94%) spesimen dilakukan pemeriksaan virus influenza. Sebanyak 
200 (12%) positif influenza, terdiri dari 46% influenza A(H3N2), 18% A(H1N1)pdm09 dan 37% influenza B. Hasil 
penilaian terhadap sistem surveilans didapatkan kesesuaian pelaksanaan untuk semua atribut surveilans melebihi 
target >80%,  kelengkapan laporan online 95%, kesesuaian kasus terhadap definisi kasus 100%, kasus yang diambil 
spesimen 94% dan hasil laboratorium diinput ke database secara online 100%.  Sistem surveilans untuk dengue dan 
infeksi arbovirus lainnya sudah terlaksana di unit rawat jalan dan gawat darurat di sentinel SARI surveilans.
Kesimpulan: SIBI dapat disesuaikan untuk menggabungkan surveilans penyakit lain yang menunjukkan 
kegunaan dan fleksibilitas dalam mendukung keamanan kesehatan global. (Health Science Journal of 
Indonesia 2018;9(1):8-13)
Kata kunci: keamanan kesehatan global, surveilans, influenza, Indonesia 
Abstract
Background: The existing national surveillance system for severe acute respiratory infection (SARI) provides 
critical information on influenza virus circulation, provides a system to control influenza outbreaks that threaten 
the safety and security of the population and feeds data into the global influenza surveillance and response 
system (GISRS). Indonesia’s ability to detect and control communicable diseases is critical for global health 
security. The aim of this study was to assess the SARI surveillance system and utility for monitoring other prior-
ity pathogens as an effort to enhance global health security. 
Methods: Surveillance attributes were assessed by reviewing records, data analysis and through interviewed 
with staffs involved in the surveillance system. All patients at six sentinel hospitals who meet the SARI case 
definition during May 2013 – April 2015 were enrolled. Epidemiological and virological data were analyzed. 
The surveillance system utility for its influenza surveillance objectives and flexibility to support surveillance of 
emerging infectious diseases were assessed.
Resuts: A total of 1,806 SARI cases were reported of which 1,697 (94%) had specimens tested for influenza vi-
ruses. Of those tested, 200 (12%) were positive, of which 46% were influenza A(H3N2), 18% A(H1N1)pdm09 
and 37% influenza B viruses. The system exceeded the targets of >80% adherence for most attributes: 95% for 
completeness of online reporting, 100% for cases adhering to the case definition, 94% for cases with specimens 
collected and 100% of laboratory results uploaded to the online database. A surveillance system for dengue and 
other arbovirus infections was established in the outpatient/emergency units at the SARI surveillance sentinel.
Conclusion: SIBI was adjusted to incorporate surveillance for other priority diseases indicating its utility and 
flexibility to support global health security. (Health Science Journal of Indonesia 2018;9(1):8-13)
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As the world’s fourth most populous country and with 
increasing international travel and trade, Indonesia’s 
ability to detect and control communicable diseases 
is critical for global health security.1-3 The existing na-
tional surveillance system for severe acute respiratory 
infection (SARI) provides critical information on in-
fluenza virus circulation, provides a system to control 
influenza outbreaks that threaten the safety and secu-
rity of the population and feeds data into the global in-
fluenza surveillance and response system (GISRS).4 
To learn how Indonesia’s SARI surveillance system 
might serve additional surveillance functions such as 
monitoring for emerging infectious diseases, its util-
ity and flexibility was evaluated. Indonesia’s SARI 
surveillance system, Surveilans Infeksi Saluran 
Pernapasan Akut Berat Indonesia (SIBI) was estab-
lished in May 2013 in accordance with the World 
Health Organization’s (WHO) influenza surveillance 
standards.5 Sites were established at inpatient wards 
in four district and two provincial hospitals that were 
geographically dispersed (Figure 1).6 The aim of this 
study is to enhance global health security, countries 
might consider adjusting existing surveillance sys-
tems to detect other priority pathogens.
METHODS
Nasal and throat swabs were collected and a 
questionnaire for clinical and demographic variables 
was administered from all patients that meeting the 
SARI case definition according to WHO influenza 
surveillance guideline.5
The SIBI’s utility for its influenza surveillance 
objectives and flexibility to support surveillance of 
emerging infectious diseases were assessed in May 
2015, 2 years after the system was established (Table 
1).7  Utility was assessed by determining if (1) the 
system outputs were fulfilling the system’s stated 
objectives and (2) the system processes were meeting 
surveillance attribute targets (Table 1).  Flexibility 
was assessed by determining whether the system’s 
data collection and analyses could be modified 
for surveillance of emerging infectious diseases 
including MERS CoV and dengue. SIBI’s guideline, 
monthly bulletins, quarterly site-monitoring visit 
reports, and surveillance data for May 2013 - April 
2015 were reviewed for supporting evidence.8 
This study was reviewed and approved by Ethical 
Clearance Committee of National Institute of Health 
Research and Development (NIHRD), Ministry of 
Health of Indonesia (No. LB.02.01/5.2/KE.198/2013 
for 2014, LB.02.01/5.2/KE.324/2015 for 2015).
RESULTS
Utility
Surveilans Infeksi Saluran Pernapasan Akut Berat 
Indonesia addressed all of its stated objectives (Table 
1). In May 2013 – April 2015, a total of 1,806 SARI 
cases were reported of which 1,697 (94%) had 
specimens tested for influenza viruses. Of those tested, 
200 (12%) were positive, of which 46% were influenza 
A(H3N2), 18% A(H1N1)pdm09 and 37% influenza B 
viruses. Detailed clinical and epidemiological findings 
for both SARI and influenza cases were reported in the 
SIBI monthly bulletin (Table 2).8  Data on underlying 
medical conditions and patient outcomes can be used 
to identify risk groups for future preventive measures 
including vaccination.9
The system exceeded the targets of >80% adherence for 
most attributes: 95% for completeness of online reporting, 
100% for cases adhering to the case definition, 94% for 
cases with specimens collected and 100% of laboratory 
results uploaded to the online database. The timeliness of 
each site’s online reporting of cases increased over time 
but only 14-52% of cases were reported by the targeted 
Monday midnight deadline. The key challenges for 
prompt online reporting of cases include the availability 
of internet connection in rural areas and the availability 
of administrative staff for data upload.
Flexibility 
Even though SIBI was established with the objective 
of conducting routine influenza surveillance, it 
demonstrated flexibility to incorporate surveillance 
of emerging infectious diseases including MERS 
CoV and novel influenza A(H7N9) virus. This 
flexibility was a result of adjusting two aspects of 
the system in December 2013: (1) updating variables 
collected to include travel history, and (2) adjusting 
the laboratory testing algorithm so that SARI cases 
with travel history to affected countries could be 
tested for MERS CoV or A(H7N9) virus infection. 
SIBI’s capacity to test for emerging infectious 
diseases especially for MERS CoV was critical 
because approximately 1.2 million Indonesians 
undertake pilgrimage to Saudi Arabia each year and 
the risk of virus introduction was deemed high.10,11 
Within 3 weeks of adjusting SIBI, the first suspect 
case of MERS CoV was detected and tested negative. 
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Table 1. Evaluation methods and findings for SIBI assessment, May 2013 – April 2015
Evaluation question Evaluation method Findings 
I. Utility:
A) Does the system address its stated 
objectives to identify:
1. SARI and influenza disease trends
2. Influenza virus subtypes and 
characteristics
3. Severity of SARI and influenza 
cases.
Review of SIBI outputs for May 
2013-April 2015 using SIBI website and 
monthly bulletins.
1. 1,806 SARI cases (1% of total 
hospitalizations), 988 (55%) of patients were 
male; 82% aged ≤15 years; 37% of SARI 
cases and 40% of positive influenza cases 
were in age group 1-4 years. The highest 
proportion (44-50%) of positive influenza 
cases per week occurred in weeks 2 to 3 in 
2014.
2. 200 (12%) SARI cases were influenza 
positive: subtype A(H3N2) (46%), A(H1N1)
pdm09 (18%) and B (37%). Virus sequences 
uploaded on international databases GISAID 
and FluNet. 
3. Pneumonia was found in 27% of SARI 
cases, and 15% of influenza positive cases. 
Case fatality ratio for SARI 2% (n=40) and 
for influenza positive 1% (n=2).
B) Does the system perform according 
to surveillance attribute targets?
Surveillance targets:
a) Completeness of data in SIBI 
database: ≥80% of case forms have 
complete data.
b) ≥80% of SARI cases adhere to the 
prescribed WHO case definition.
c) ≥90% of SARI cases have 
specimens collected for diagnostic 
testing.
d) ≥80% laboratory results uploaded to 
their case forms online in the system 
database.
e) ≥80% of cases uploaded to the 
online database by midnight each 
Monday.
a) 95% of SIBI case reports have complete 
data.
b) 100% of cases adhere to prescribed case 
definition
c) 94% of cases have specimens collected.
d) 100% laboratory results were uploaded to 
online database.
e) In 2013: 14% cases uploaded by Monday 
midnight (hospital range 4-31%); in 2014: 
52% (hospital range 9-88%); In January-
April 2015: 52% (hospital range 32-92%).
II. Flexibility: 
Can the system be adjusted for 
surveillance of emerging infectious 
diseases?
Evidence of flexibility in updating:
a) Data variables collected.
b) Algorithm for laboratory diagnostic 
testing.
c) Surveillance for other priority 
syndromes introduced.
a) Travel history variable added 6 months after 
system started. 
b) SARI cases with travel history to A(H7N9) 
virus and MERS CoV affected countries 
could be tested for these diseases. 
c) Sistem Surveilans Sentinel Dengue was 
introduced to monitor Dengue serotype 
distribution and trends, and then expanded 
to include surveillance for other arboviruses 
including Chikungunya and Zika.
Abbreviations: SARI=Severe acute respiratory infection; GISAID=Global Initiative on Sharing Avian Influenza Data, MERS CoV=Middle East 
Respiratory Syndrome Coronavirus.
By May 2015, 21 cases of suspected MERS CoV 
were detected by SIBI and all tested negative. At 
each adjustment of SIBI, the Ministry of Health 
provided refresher training, monitoring, and updated 
guidelines to the sentinel sites to ensure that case 
enrolment, questionnaire administration, specimen 
collection, and reporting were correct.12 
In 2014, as a result of improved performance on 
surveillance system attributes, a further innovation 
was introduced at each hospital site. A surveillance 
system for dengue and other arbovirus infections was 
established in the outpatient/emergency units. This 
system, known as  Sistem Surveilans Sentinel Dengue, 
was established in September 2014 and provides 
data on regional dengue serotype trends and patient 
clinical presentation. SIBI and Sistem Surveilans 
Sentinel Dengue enable cost efficiency as specimens 
are shipped together (from sites up to 1500 miles 
away) to the Ministry of Health laboratory and the 
administrative resources are shared.13 This innovation 
was based on the WHO influenza standards that 
recommended introduction of surveillance for other 
priority syndromes at SARI hospital sites.4 
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Male 988 (55) 110 (55) 
Female 818 (45) 90 (45) 
Age group (yrs)
<1 506 (28) 24 (12) 
1 – 4  676 (37) 80 (40) 
5 – 14 296 (17) 43 (22) 
15 – 49 167 (9) 18 (9) 
50 – 64 102 (6) 22 (11) 
≥65  59 (3) 13 (7) 
Symptoms*
History of fever 1804 (100) 200 (100) 
Temperature  ≥38°C 1139 (63) 143 (72) 
Cough 1800(100) 200 (100) 
Sore throat 439 (24) 74 (37) 
Difficulty breathing 916 (51) 83 (42) 
Vomiting 675 (37) 80 (40) 
Pleuritic chest pain 222 (12) 31 (16) 
Rhonchi 738 (41) 64 (32) 
Diarrhea 355 (20) 36 (18) 
Medical condition*
Smoker 117 (7) 23 (12) 
Asthma 105 (6) 21 (11) 
Neurological disorder 12 (1) 1 (1) 
Pregnancy 5 (0.3) 0 (0) 
Diabetes 35 (2) 5 (3) 
Chronic kidney disease 6 (0.3) 2 (1) 
Tuberculosis 40 (2) 5 (3) 
Cardiovascular  disease 24 (1) 5 (3) 
Chronic obstructive pulmonary disease 44 (2) 12 (6) 
Immunosuppression 3 (0.2) 0 (0) 
Chronic liver disease 2 ( 0.1) 0 (0) 
Blood disorder 4 (0.2) 1 (1) 
Influenza vaccination 9 (1) 2 (1) 
Cancer 3 (0.2) 0 (0) 
Obesity 12 (1) 2 (1) 
Discharge condition
Death 40 (2) 2 (1) 
Radiologic examination
Chest radiograph obtained 697 (39) 58 (29)
Pneumonia on chest radiograph 480 (27) 30 (15)




Chest indrawing 246(19) 10 (10)
Unable to drink 69 (6) 3 (3)
Convulsion 159 (13) 21 (20)
Stridor 70 (6) 4 (4)
Lethargy/ reduced consciousness 31 (3) 2 (2)
Abbreviation: IMCI = Integrated Management of Childhood Illness
*Patient might have more than one symptom/condition 
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DISCUSSION
The SIBI has operated for over three years in 
Indonesia and yields high quality data from 
geographically dispersed hospitals. However, as the 
system is relatively new and timeliness of online 
case reporting is still below target, there is a need 
to continually strengthen its operation. With only 
six sites, SIBI cannot replace nationwide indicator 
or event-based surveillance systems for the detection 
of emerging infectious diseases such as MERS CoV. 
However, SIBI serves as a second line of defense 
for the detection of newly emerging diseases as sites 
are actively searching for patients meeting the case 
definition. As SIBI operates year-round, it helps 
maintain the continuous operation of surveillance 
capacities such as laboratory diagnostic skills, 
specimen collection supplies, supply management 
and specimen shipment chains. This enhances 
Indonesia’s readiness for emerging infectious 
diseases and other disease threats.  
This evaluation, in context of the system’s utility and 
flexibility to address global health security needs, 
found that SIBI is highly valuable in addressing 
the current objectives for influenza surveillance 
as well as flexible for incorporating surveillance 
for other emerging infectious diseases. Future 
SIBI enhancements envisioned include work on 
other vaccine-preventable illnesses, including 
pneumococcal disease and respiratory syncytial virus 
infection, to provide baseline data for programmatic 
and policy decision-making. 
For global health security, it is important for 
countries to increase disease surveillance capacities, 
including surveillance for emerging infectious 
diseases. Indonesia’s success is critical as it is the 
world’s fourth most populous country that spans over 
3000 miles (5000 km) with increasing international 
travel and trade.  Indonesia’s severe acute respiratory 
infection surveillance system (SIBI), which focuses 
on influenza surveillance, was evaluated to assess its 
broader surveillance flexibility.12,14
SIBI successfully addressed the current influenza 
surveillance objectives, by exceeding 4 of 5. By add-
ing additional variables and testing algorithms, it 
was sufficiently flexible to incorporate surveillance 
 Figure 1. Sentinel  site of  Surveillance ISPA BERAT Indonesia (SIBI)
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for other emerging infectious diseases such as Mid-
dle East Respiratory Syndrome Coronavirus.15 The 
inpatient system for influenza was also augmented 
by an outpatient surveillance system for dengue to 
increase cost efficiency.
In conclusion, The existing surveillance systems 
can be adjust to detect other priority pathogens and 
enhance global health security. Indonesia is investing 
in geographically-dispersed surveillance sites to 
generate high quality data that can inform various 
disease control programs. 
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